麻豆传媒

Oncology/Hematology >

Other Cancers

News, opinions and meeting coverage in oncology/hematology.

QoL Benefits with Palliative Surgery for Gastric Cancer

Solid food intake facilitated, anxiety and pain decreased

Nivolumab Slows Advanced Gastric Cancer

Significant reduction in hazards for survival, PFS in pretreated patients

PET-Guided Therapy Switch for Esophageal Cancer

Improved response with switch from ineffective treatment

Amyloidosis Treatments Miss the Heart of the Problem

Only modest improvement in end organ function

Opiate Alternatives in Cancer Pain

ASRA president discusses the options in this 麻豆传媒 video

Former NCI Chief Niederhuber Shifts Gears

At age 78, still active in research and administration

Is Keytruda Better than Opdivo?

Trial results begin to suggest an advantage

Fraud Rounds: Grant Fakery Earns Practice Ban

Cancer researcher struck from U.K. medical register after fabricating data in grant applications

Practice Changer: Tandem Transplant for Neuroblastoma

13% absolute increase in 3-year event-free survival

Antibody Shines in Advanced Gastric Cancer

IMAB362 leads to longer remission, better survival

Gemcitabine-Capecitabine Tx: The New Standard in Pancreatic Ca?

Five-year survival reaches all-time high in post-surgical patients

Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

When "Unremarkable" Is Not Clear Enough

Radiology reports need to be held to higher standards, argues Saurabh Jha, MD

Calling a Doctor by His or Her First Name

It's different without a longstanding relationship, says James C. Salwitz, MD

Dedicating a Career to Diversity and Disparities

NMA president Edith Mitchell, MD, laments racial gaps in medicine

No DFS Benefit With Chemoradiation in Bladder Cancer

Adjuvant combo reduces local recurrence after cystectomy

'Failure to Communicate' Drives Misdiagnosis

Electronic medical records also need to be improved, says Mark Graber, MD

Hybrid Academic-Community Cancer Centers Take Shape

Emerging model takes cutting-edge oncology into the community

Giving Patients Evidence-Based Reassurance

In response to the Less-is-More series, here are five evidence-based tips for reassuring patients

How ASCO'S First Clinical Trial -- TAPUR -- Came To Be

ASCO's entry will evaluate off-label use of targeted agents

Part 2: Oncologists Weigh In on PBS Cancer Documentary

Six specialists share their impressions of Ken Burns' cancer opus.

Brain Cancer: Did '60 Minutes' Report Raise False Hope?

Glioblastoma virotherapy touted on CBS program is promising but preliminary.

AAD: Frog Enzyme Clears Genital Warts

Summaries of late-breaking research from the dermatology meeting.

Frankie the Dog Fetches - and Finds Thyroid Cancer?

Canine trained in cancer scent detection gives few false positives in early test.

HDAC Inhibitor OK'd for Multiple Myeloma

Panobinostat targets histone deacetylases; first of its kind to win approval in myeloma.

Predicting Death in Advanced Cancer

Study offers clues to guide clinicians, families about end of life.

No Need for Cancer Watch in Cirrhotic Wilson's Disease

Hepatocellular carcinoma is too infrequent to merit regular surveillance.

Do Statins Up a Woman's Risk for Thyroid Cancer?

Estrogen may neutralize the cancer-protective effects of cholesterol-lowering drugs.

That's Not Chronic Lyme, It's Cancer

Three case reports demonstrate the risks of "assuming that patients have chronic Lyme disease."

New Melanomas Likely to Recur at Same Rate

CHICAGO -- A diagnosis of in situ or invasive melanoma conferred a similar long-term risk of invasive melanoma recurrence, a 40-year retrospective review showed.

Morning Break: The B.O. Talk, No Love for Niacin

Health news and commentary from around the Web, gathered by the 麻豆传媒 staff.

AMA Clamps Down on MOC, But Punts on Gun Regs

CHICAGO -- The AMA鈥檚 House of Delegates drew the line on this year's hot button topic -- maintenance of certification (MOC), saying it should not be mandatory, nor should it be a condition of licensure.

Medtronic's Infuse Moves From Operating Room to Courtroom

An investigative series by 麻豆传媒/Milwaukee Journal Sentinel has been tracking the spinal fusion device called Infuse in a 4-year-long series and now reports how a flawed FDA system for device approval may have led to a long string of adverse events culminating in thousands of liability suits.

FDA Warns of Cancer Risk With Laparoscopic Device

WASHINGTON -- Hysterectomy and procedures to remove uterine fibroids should avoid use of laparoscopic power morcellation, according to a safety advisory from the Food and Drug Administration.

Cancer Ascites Responds to Outpatient Tx

TAMPA, Fla. -- Outpatient treatment of malignant ascites with a monoclonal antibody proved safe and feasible and led to a survival benefit in gynecologic cancer patients who could receive chemotherapy, a small clinical study showed.

OncoBriefs: Myeloma Tx, In Situ Melanoma

Superficial melanoma conferred a risk of recurrent invasive melanoma similar to that of primary invasive melanoma, Australian investigators reported. The study is one of several oncology-related news items summarized in OncoBriefs.

Is There a Flaw in This Large Vitamin D Trial?

A co-principal investigator of the VITAL trial addresses the possibility that out-of-study testing of vitamin D levels and initiation of high-dose supplementation could be a limitation, but not a serious one.

Combo Active in Neuroendocrine Cancers

SAN FRANCISCO -- More than 90% of patients with neuroendocrine tumors had objective responses or stable disease when treated with an off-the-shelf chemotherapy doublet, results of a small study showed.

Colonoscopies: The Longer the Better

Polyp and adenoma detection rates were highest when the colonoscopy withdrawal time was 9 minutes long, near the upper limit of the recommended 6 to 10 minutes withdrawal time, researchers found.

High IgG Signals Autoimmunity in Kids

High levels of immunoglobulin G (IgG) in children -- and particularly girls -- were associated with the development of autoimmune disease, researchers found.

鈥�

25